Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.

Improve treatment decisions and outcomes in cancer - Making precision medicine a reality for millions

Reference number
Coordinator Stratipath AB
Funding from Vinnova SEK 900 000
Project duration April 2020 - March 2021
Status Completed
Venture Innovative Startups
Call Innovative Startups step 2 spring 2020

Important results from the project

** Denna text är maskinöversatt ** The project reached its most important objective regarding further development of the AI model for stratifying breast cancer and that we secured long-term funding to be able to reach the market.

Expected long term effects

** Denna text är maskinöversatt ** The project created conditions for us to get closer to the market, minimize risks in the project going forward, which means that we can now increase the pace and the team.

Approach and implementation

** Denna text är maskinöversatt ** The project has been affected by COVID-19, which has meant that we have had to change the structure a little and more work has been done within the company than was initially planned. However, it did not affect the outcome even though it took a little longer. The advantage is that the knowledge that has now been built remains in the company.

The project description has been provided by the project members themselves and the text has not been looked at by our editors.

Last updated 27 February 2023

Reference number 2020-00156